STAT3 and lung carcinoma: In the context of lung cancer, APS suppresses the S1PR1/STAT3 signaling pathway, which reduces the premetastatic niche, a distant secondary microenvironment prepared for future metastatic growth, which is essential for preventing metastasis [160].